GSE,Sample_title,Sample_geo_accession,Sample_status,Sample_submission_date,Sample_last_update_date,Sample_type,Sample_channel_count,Sample_source_name_ch1,Sample_organism_ch1,Sample_taxid_ch1,Sample_treatment_protocol_ch1,Sample_growth_protocol_ch1,Sample_molecule_ch1,Sample_extract_protocol_ch1,Sample_data_processing,Sample_platform_id,Sample_contact_name,Sample_contact_email,Sample_contact_department,Sample_contact_institute,Sample_contact_address,Sample_contact_city,Sample_contact_state,Sample_contact_zip/postal_code,Sample_contact_country,Sample_instrument_model,Sample_library_selection,Sample_library_source,Sample_library_strategy,Sample_series_id,Sample_data_row_count,file,file_url,sample_name,file_size,type,cell type,tissue,genotype,Genome_build,BioSample,SRA
GSE145182,APC_CTRL_atacseq_REP1,GSM4308120,Public on Feb 25 2020,Feb 12 2020,Feb 26 2020,SRA,1,APC_CTRL_ATAC-seq,Homo sapiens,9606,"For TGF-pathway activation, organoids were cultured without A83-01 and in 10 ng/ml recombinant TGFB1","Culture medium of Human Intestinal Organoids contained Advanced DMEM/F12 supplemented with 10 mM HEPES, 1x Glutamax, 1% Penicillin/Streptomycin, 1x N2, 1x B27, 1.25 mM N-acetylcysteine, 50% WNT3A-conditioned medium (CM), 20% RSPO1-CM 20%, 10% NOGGIN-CM (all CM produced in-house), 10 mM Nicotinamide, 50 ng/ml human EGF, 10 nM Gastrin, 0.5 µM TGFß type I receptor inhibitor A83-01 and 10 µM p38-inhibitor SB202190",genomic DNA,"Lysis buffer, For ATAC-Seq with hSI organoids, organoids were dissociated into single cells and 50,000 cells were lysed in 50 µl cold Lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630). After centrifugation at 500 g for 10 min at 4˚C, cells were resuspended in 1X transposition mix (Illumina; 25 µl Tagment DNA Buffer, 2.5 µl Tagment DNA Enzyme, 22.5 µl ddH2O) and incubated for 30 min at 37˚C on a shaker at 300 rpm. Immediately after the transposition reaction, DNA was purified using the QIAgen MinElute PCR Purification Kit according to the manufacturer’s instructions. Library was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 5 cycles. To remove large DNA fragments, the PCR reaction was incubated with 0.55X AMPure XP beads (Beckman Coulter) and the unbound supernatant was subsequently purified with QIAgen MinElute coloumns. Again, DNA was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 9 cycles. Finally, to remove primers and small DNA fragments, PCR reaction was bead-purified with 1.8X AMPure XP beads.","Raw sequencing reads were filtered for low-quality after adapter removal and aligned on GRCh38 using Bowtie2  with default mapping parameters, PCR duplicates were removed using Picard. The mapped reads of all replicates were merged for each condition prior to peak calling. Peaks were called on each sample using MACS2 with “--nomodel --shift -100 --extsize 200”, to obtain a consensus peak set for each sample. The peak set was used to build a count matrix using the aligned reads for all samples and their replicates., Differential peaks between sample groups were identified using edgeR. For this, the count matrix was filtered for peaks with low coverage across all samples based on minimum read count of 10 for each sample. The remaining counts were normalized using the total library size as well as edgeR’s TMM derived normalization factors., Between two sample groups, only regions with a log fold change above > 0.5 and an FDR value < 0.05 were considered as differentially accessible for further analysis. The peaks were annotated using HOMER",GPL20301,"giancarlo,,russo",giancarlo.russo@fgcz.ethz.ch,Functional Genomics Center Zurich,ETH/University of Zurich,winterthurerstrasse 190,Zurich,Schweiz,8057,Switzerland,Illumina HiSeq 4000,other,genomic,ATAC-seq,"GSE145182, GSE145185",0,GSM4308120_atacseq_APC_0h_merged_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4308nnn/GSM4308120/suppl/GSM4308120_atacseq_APC_0h_merged_peaks.narrowPeak.gz,APC_CTRL_atacseq_REP1,1314746,NARROWPEAK,organoids,Human small intestine,APC-KO,GRCh38,https://www.ncbi.nlm.nih.gov/biosample/SAMN14088514,https://www.ncbi.nlm.nih.gov/sra?term
GSE145182,APC_TREAT_atacseq_REP1,GSM4308122,Public on Feb 25 2020,Feb 12 2020,Feb 26 2020,SRA,1,APC_TREAT_ATAC-seq,Homo sapiens,9606,"For TGF-pathway activation, organoids were cultured without A83-01 and in 10 ng/ml recombinant TGFB1","Culture medium of Human Intestinal Organoids contained Advanced DMEM/F12 supplemented with 10 mM HEPES, 1x Glutamax, 1% Penicillin/Streptomycin, 1x N2, 1x B27, 1.25 mM N-acetylcysteine, 50% WNT3A-conditioned medium (CM), 20% RSPO1-CM 20%, 10% NOGGIN-CM (all CM produced in-house), 10 mM Nicotinamide, 50 ng/ml human EGF, 10 nM Gastrin, 0.5 µM TGFß type I receptor inhibitor A83-01 and 10 µM p38-inhibitor SB202190",genomic DNA,"Lysis buffer, For ATAC-Seq with hSI organoids, organoids were dissociated into single cells and 50,000 cells were lysed in 50 µl cold Lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630). After centrifugation at 500 g for 10 min at 4˚C, cells were resuspended in 1X transposition mix (Illumina; 25 µl Tagment DNA Buffer, 2.5 µl Tagment DNA Enzyme, 22.5 µl ddH2O) and incubated for 30 min at 37˚C on a shaker at 300 rpm. Immediately after the transposition reaction, DNA was purified using the QIAgen MinElute PCR Purification Kit according to the manufacturer’s instructions. Library was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 5 cycles. To remove large DNA fragments, the PCR reaction was incubated with 0.55X AMPure XP beads (Beckman Coulter) and the unbound supernatant was subsequently purified with QIAgen MinElute coloumns. Again, DNA was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 9 cycles. Finally, to remove primers and small DNA fragments, PCR reaction was bead-purified with 1.8X AMPure XP beads.","Raw sequencing reads were filtered for low-quality after adapter removal and aligned on GRCh38 using Bowtie2  with default mapping parameters, PCR duplicates were removed using Picard. The mapped reads of all replicates were merged for each condition prior to peak calling. Peaks were called on each sample using MACS2 with “--nomodel --shift -100 --extsize 200”, to obtain a consensus peak set for each sample. The peak set was used to build a count matrix using the aligned reads for all samples and their replicates., Differential peaks between sample groups were identified using edgeR. For this, the count matrix was filtered for peaks with low coverage across all samples based on minimum read count of 10 for each sample. The remaining counts were normalized using the total library size as well as edgeR’s TMM derived normalization factors., Between two sample groups, only regions with a log fold change above > 0.5 and an FDR value < 0.05 were considered as differentially accessible for further analysis. The peaks were annotated using HOMER",GPL20301,"giancarlo,,russo",giancarlo.russo@fgcz.ethz.ch,Functional Genomics Center Zurich,ETH/University of Zurich,winterthurerstrasse 190,Zurich,Schweiz,8057,Switzerland,Illumina HiSeq 4000,other,genomic,ATAC-seq,"GSE145182, GSE145185",0,GSM4308122_atacseq_APC_24h_merged_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4308nnn/GSM4308122/suppl/GSM4308122_atacseq_APC_24h_merged_peaks.narrowPeak.gz,APC_TREAT_atacseq_REP1,1187937,NARROWPEAK,organoids,Human small intestine,APC-KO,GRCh38,https://www.ncbi.nlm.nih.gov/biosample/SAMN14088512,https://www.ncbi.nlm.nih.gov/sra?term
GSE145182,ARID1A_CTRL_atacseq_REP1,GSM4308124,Public on Feb 25 2020,Feb 12 2020,Feb 26 2020,SRA,1,ARID1A_CTRL_ATAC-seq,Homo sapiens,9606,"For TGF-pathway activation, organoids were cultured without A83-01 and in 10 ng/ml recombinant TGFB1","Culture medium of Human Intestinal Organoids contained Advanced DMEM/F12 supplemented with 10 mM HEPES, 1x Glutamax, 1% Penicillin/Streptomycin, 1x N2, 1x B27, 1.25 mM N-acetylcysteine, 50% WNT3A-conditioned medium (CM), 20% RSPO1-CM 20%, 10% NOGGIN-CM (all CM produced in-house), 10 mM Nicotinamide, 50 ng/ml human EGF, 10 nM Gastrin, 0.5 µM TGFß type I receptor inhibitor A83-01 and 10 µM p38-inhibitor SB202190",genomic DNA,"Lysis buffer, For ATAC-Seq with hSI organoids, organoids were dissociated into single cells and 50,000 cells were lysed in 50 µl cold Lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630). After centrifugation at 500 g for 10 min at 4˚C, cells were resuspended in 1X transposition mix (Illumina; 25 µl Tagment DNA Buffer, 2.5 µl Tagment DNA Enzyme, 22.5 µl ddH2O) and incubated for 30 min at 37˚C on a shaker at 300 rpm. Immediately after the transposition reaction, DNA was purified using the QIAgen MinElute PCR Purification Kit according to the manufacturer’s instructions. Library was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 5 cycles. To remove large DNA fragments, the PCR reaction was incubated with 0.55X AMPure XP beads (Beckman Coulter) and the unbound supernatant was subsequently purified with QIAgen MinElute coloumns. Again, DNA was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 9 cycles. Finally, to remove primers and small DNA fragments, PCR reaction was bead-purified with 1.8X AMPure XP beads.","Raw sequencing reads were filtered for low-quality after adapter removal and aligned on GRCh38 using Bowtie2  with default mapping parameters, PCR duplicates were removed using Picard. The mapped reads of all replicates were merged for each condition prior to peak calling. Peaks were called on each sample using MACS2 with “--nomodel --shift -100 --extsize 200”, to obtain a consensus peak set for each sample. The peak set was used to build a count matrix using the aligned reads for all samples and their replicates., Differential peaks between sample groups were identified using edgeR. For this, the count matrix was filtered for peaks with low coverage across all samples based on minimum read count of 10 for each sample. The remaining counts were normalized using the total library size as well as edgeR’s TMM derived normalization factors., Between two sample groups, only regions with a log fold change above > 0.5 and an FDR value < 0.05 were considered as differentially accessible for further analysis. The peaks were annotated using HOMER",GPL20301,"giancarlo,,russo",giancarlo.russo@fgcz.ethz.ch,Functional Genomics Center Zurich,ETH/University of Zurich,winterthurerstrasse 190,Zurich,Schweiz,8057,Switzerland,Illumina HiSeq 4000,other,genomic,ATAC-seq,"GSE145182, GSE145185",0,GSM4308124_atacseq_ARID1A_0h_merged_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4308nnn/GSM4308124/suppl/GSM4308124_atacseq_ARID1A_0h_merged_peaks.narrowPeak.gz,ARID1A_CTRL_atacseq_REP1,743132,NARROWPEAK,organoids,Human small intestine,"APC-KO, ARID1A-KO",GRCh38,https://www.ncbi.nlm.nih.gov/biosample/SAMN14088510,https://www.ncbi.nlm.nih.gov/sra?term
GSE145182,ARID1A_TREAT_atacseq_REP1,GSM4308126,Public on Feb 25 2020,Feb 12 2020,Feb 26 2020,SRA,1,ARID1A_TREAT_ATAC-seq,Homo sapiens,9606,"For TGF-pathway activation, organoids were cultured without A83-01 and in 10 ng/ml recombinant TGFB1","Culture medium of Human Intestinal Organoids contained Advanced DMEM/F12 supplemented with 10 mM HEPES, 1x Glutamax, 1% Penicillin/Streptomycin, 1x N2, 1x B27, 1.25 mM N-acetylcysteine, 50% WNT3A-conditioned medium (CM), 20% RSPO1-CM 20%, 10% NOGGIN-CM (all CM produced in-house), 10 mM Nicotinamide, 50 ng/ml human EGF, 10 nM Gastrin, 0.5 µM TGFß type I receptor inhibitor A83-01 and 10 µM p38-inhibitor SB202190",genomic DNA,"Lysis buffer, For ATAC-Seq with hSI organoids, organoids were dissociated into single cells and 50,000 cells were lysed in 50 µl cold Lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630). After centrifugation at 500 g for 10 min at 4˚C, cells were resuspended in 1X transposition mix (Illumina; 25 µl Tagment DNA Buffer, 2.5 µl Tagment DNA Enzyme, 22.5 µl ddH2O) and incubated for 30 min at 37˚C on a shaker at 300 rpm. Immediately after the transposition reaction, DNA was purified using the QIAgen MinElute PCR Purification Kit according to the manufacturer’s instructions. Library was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 5 cycles. To remove large DNA fragments, the PCR reaction was incubated with 0.55X AMPure XP beads (Beckman Coulter) and the unbound supernatant was subsequently purified with QIAgen MinElute coloumns. Again, DNA was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 9 cycles. Finally, to remove primers and small DNA fragments, PCR reaction was bead-purified with 1.8X AMPure XP beads.","Raw sequencing reads were filtered for low-quality after adapter removal and aligned on GRCh38 using Bowtie2  with default mapping parameters, PCR duplicates were removed using Picard. The mapped reads of all replicates were merged for each condition prior to peak calling. Peaks were called on each sample using MACS2 with “--nomodel --shift -100 --extsize 200”, to obtain a consensus peak set for each sample. The peak set was used to build a count matrix using the aligned reads for all samples and their replicates., Differential peaks between sample groups were identified using edgeR. For this, the count matrix was filtered for peaks with low coverage across all samples based on minimum read count of 10 for each sample. The remaining counts were normalized using the total library size as well as edgeR’s TMM derived normalization factors., Between two sample groups, only regions with a log fold change above > 0.5 and an FDR value < 0.05 were considered as differentially accessible for further analysis. The peaks were annotated using HOMER",GPL20301,"giancarlo,,russo",giancarlo.russo@fgcz.ethz.ch,Functional Genomics Center Zurich,ETH/University of Zurich,winterthurerstrasse 190,Zurich,Schweiz,8057,Switzerland,Illumina HiSeq 4000,other,genomic,ATAC-seq,"GSE145182, GSE145185",0,GSM4308126_atacseq_ARID1A_24h_merged_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4308nnn/GSM4308126/suppl/GSM4308126_atacseq_ARID1A_24h_merged_peaks.narrowPeak.gz,ARID1A_TREAT_atacseq_REP1,719719,NARROWPEAK,organoids,Human small intestine,"APC-KO, ARID1A-KO",GRCh38,https://www.ncbi.nlm.nih.gov/biosample/SAMN14088508,https://www.ncbi.nlm.nih.gov/sra?term
GSE145182,SMARCA4_CTRL_atacseq_REP1,GSM4308128,Public on Feb 25 2020,Feb 12 2020,Feb 26 2020,SRA,1,SMARCA4_CTRL_ATAC-seq,Homo sapiens,9606,"For TGF-pathway activation, organoids were cultured without A83-01 and in 10 ng/ml recombinant TGFB1","Culture medium of Human Intestinal Organoids contained Advanced DMEM/F12 supplemented with 10 mM HEPES, 1x Glutamax, 1% Penicillin/Streptomycin, 1x N2, 1x B27, 1.25 mM N-acetylcysteine, 50% WNT3A-conditioned medium (CM), 20% RSPO1-CM 20%, 10% NOGGIN-CM (all CM produced in-house), 10 mM Nicotinamide, 50 ng/ml human EGF, 10 nM Gastrin, 0.5 µM TGFß type I receptor inhibitor A83-01 and 10 µM p38-inhibitor SB202190",genomic DNA,"Lysis buffer, For ATAC-Seq with hSI organoids, organoids were dissociated into single cells and 50,000 cells were lysed in 50 µl cold Lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630). After centrifugation at 500 g for 10 min at 4˚C, cells were resuspended in 1X transposition mix (Illumina; 25 µl Tagment DNA Buffer, 2.5 µl Tagment DNA Enzyme, 22.5 µl ddH2O) and incubated for 30 min at 37˚C on a shaker at 300 rpm. Immediately after the transposition reaction, DNA was purified using the QIAgen MinElute PCR Purification Kit according to the manufacturer’s instructions. Library was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 5 cycles. To remove large DNA fragments, the PCR reaction was incubated with 0.55X AMPure XP beads (Beckman Coulter) and the unbound supernatant was subsequently purified with QIAgen MinElute coloumns. Again, DNA was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 9 cycles. Finally, to remove primers and small DNA fragments, PCR reaction was bead-purified with 1.8X AMPure XP beads.","Raw sequencing reads were filtered for low-quality after adapter removal and aligned on GRCh38 using Bowtie2  with default mapping parameters, PCR duplicates were removed using Picard. The mapped reads of all replicates were merged for each condition prior to peak calling. Peaks were called on each sample using MACS2 with “--nomodel --shift -100 --extsize 200”, to obtain a consensus peak set for each sample. The peak set was used to build a count matrix using the aligned reads for all samples and their replicates., Differential peaks between sample groups were identified using edgeR. For this, the count matrix was filtered for peaks with low coverage across all samples based on minimum read count of 10 for each sample. The remaining counts were normalized using the total library size as well as edgeR’s TMM derived normalization factors., Between two sample groups, only regions with a log fold change above > 0.5 and an FDR value < 0.05 were considered as differentially accessible for further analysis. The peaks were annotated using HOMER",GPL20301,"giancarlo,,russo",giancarlo.russo@fgcz.ethz.ch,Functional Genomics Center Zurich,ETH/University of Zurich,winterthurerstrasse 190,Zurich,Schweiz,8057,Switzerland,Illumina HiSeq 4000,other,genomic,ATAC-seq,"GSE145182, GSE145185",0,GSM4308128_atacseq_SMARCA4_0h_merged_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4308nnn/GSM4308128/suppl/GSM4308128_atacseq_SMARCA4_0h_merged_peaks.narrowPeak.gz,SMARCA4_CTRL_atacseq_REP1,602339,NARROWPEAK,organoids,Human small intestine,"APC-KO, SMARCA4-KO",GRCh38,https://www.ncbi.nlm.nih.gov/biosample/SAMN14088506,https://www.ncbi.nlm.nih.gov/sra?term
GSE145182,SMARCA4_TREAT_atacseq_REP1,GSM4308130,Public on Feb 25 2020,Feb 12 2020,Feb 26 2020,SRA,1,SMARCA4_TREAT_ATAC-seq,Homo sapiens,9606,"For TGF-pathway activation, organoids were cultured without A83-01 and in 10 ng/ml recombinant TGFB1","Culture medium of Human Intestinal Organoids contained Advanced DMEM/F12 supplemented with 10 mM HEPES, 1x Glutamax, 1% Penicillin/Streptomycin, 1x N2, 1x B27, 1.25 mM N-acetylcysteine, 50% WNT3A-conditioned medium (CM), 20% RSPO1-CM 20%, 10% NOGGIN-CM (all CM produced in-house), 10 mM Nicotinamide, 50 ng/ml human EGF, 10 nM Gastrin, 0.5 µM TGFß type I receptor inhibitor A83-01 and 10 µM p38-inhibitor SB202190",genomic DNA,"Lysis buffer, For ATAC-Seq with hSI organoids, organoids were dissociated into single cells and 50,000 cells were lysed in 50 µl cold Lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630). After centrifugation at 500 g for 10 min at 4˚C, cells were resuspended in 1X transposition mix (Illumina; 25 µl Tagment DNA Buffer, 2.5 µl Tagment DNA Enzyme, 22.5 µl ddH2O) and incubated for 30 min at 37˚C on a shaker at 300 rpm. Immediately after the transposition reaction, DNA was purified using the QIAgen MinElute PCR Purification Kit according to the manufacturer’s instructions. Library was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 5 cycles. To remove large DNA fragments, the PCR reaction was incubated with 0.55X AMPure XP beads (Beckman Coulter) and the unbound supernatant was subsequently purified with QIAgen MinElute coloumns. Again, DNA was amplified with Nextera Sequencing primers in NEBNext Q5 Hot Start HiFi 2X PCR master mix for 9 cycles. Finally, to remove primers and small DNA fragments, PCR reaction was bead-purified with 1.8X AMPure XP beads.","Raw sequencing reads were filtered for low-quality after adapter removal and aligned on GRCh38 using Bowtie2  with default mapping parameters, PCR duplicates were removed using Picard. The mapped reads of all replicates were merged for each condition prior to peak calling. Peaks were called on each sample using MACS2 with “--nomodel --shift -100 --extsize 200”, to obtain a consensus peak set for each sample. The peak set was used to build a count matrix using the aligned reads for all samples and their replicates., Differential peaks between sample groups were identified using edgeR. For this, the count matrix was filtered for peaks with low coverage across all samples based on minimum read count of 10 for each sample. The remaining counts were normalized using the total library size as well as edgeR’s TMM derived normalization factors., Between two sample groups, only regions with a log fold change above > 0.5 and an FDR value < 0.05 were considered as differentially accessible for further analysis. The peaks were annotated using HOMER",GPL20301,"giancarlo,,russo",giancarlo.russo@fgcz.ethz.ch,Functional Genomics Center Zurich,ETH/University of Zurich,winterthurerstrasse 190,Zurich,Schweiz,8057,Switzerland,Illumina HiSeq 4000,other,genomic,ATAC-seq,"GSE145182, GSE145185",0,GSM4308130_atacseq_SMARCA4_24h_merged_peaks.narrowPeak.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4308nnn/GSM4308130/suppl/GSM4308130_atacseq_SMARCA4_24h_merged_peaks.narrowPeak.gz,SMARCA4_TREAT_atacseq_REP1,639728,NARROWPEAK,organoids,Human small intestine,"APC-KO, SMARCA4-KO",GRCh38,https://www.ncbi.nlm.nih.gov/biosample/SAMN14088504,https://www.ncbi.nlm.nih.gov/sra?term
